Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study

  • Bae, Hyoung Won (Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine) ;
  • Kim, Ji Hyun (Siloam Eye Hospital) ;
  • Kim, Sangah (Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine) ;
  • Kim, Minkyo (Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine) ;
  • Lee, Naeun (Department of Ophthalmology, Hallym Hospital) ;
  • Hong, Samin (Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine) ;
  • Seong, Gong Je (Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine) ;
  • Kim, Chan Yun (Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine)
  • Received : 2014.04.25
  • Accepted : 2014.07.16
  • Published : 2015.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Many patients with glaucoma have difficulty using antiglaucoma eye drops because of dry eye symptom. In this prospective, randomized, double-blind, placebo-controlled study, we evaluated the effect of Korean Red Ginseng on dry eye syndrome in patients with glaucoma treated with antiglaucoma eye drops. Methods: Forty-nine participants were allocated to the Korean Red Ginseng (3 g/day; n = 24) or placebo (n = 25) groups for 8 weeks. Tear film stability, fluorescein corneal staining, conjunctival hyperemia, tear production, grade of meibomian gland dysfunction, and dry eye questionnaire (Ocular Surface Disease Index) were evaluated at baseline and on completion of the treatment. Results: Almost all patients displayed dry eye symptoms and signs at baseline. After the 8-week intervention, Korean Red Ginseng supplementation significantly improved the tear film stability and total Ocular Surface Disease Index score, as compared to placebo (p < 0.01). Conclusion: Korean Red Ginseng supplementation may provide an additional treatment option for dry eye and patients with glaucoma using antiglaucoma eye drops.

Keywords

Acknowledgement

Supported by : Korean Society of Ginseng

References

  1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82:844-51.
  2. Pizzarello L, Abiose A, Ffytche T, Duerksen R, Thulasiraj R, Taylor H, Faal H, Rao G, Kocur I, Resnikoff S. VISION 2020: the Right to Sight: a global initiative to eliminate avoidable blindness. Arch Ophthal 2004;122:615-20. https://doi.org/10.1001/archopht.122.4.615
  3. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish 2nd RK, Wilson MR, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary openangle glaucoma. Arch Ophthal 2002;120:714-20. https://doi.org/10.1001/archopht.120.6.714
  4. Higginbotham EJ, Schuman JS, Goldberg I, Gross RL, VanDenburgh AM, Chen K, Whitcup SM. One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthal 2002;120:1286-93. https://doi.org/10.1001/archopht.120.10.1286
  5. Camras CB. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group. Ophthalmology 1996;103:138-47. https://doi.org/10.1016/S0161-6420(96)30749-5
  6. Garcia-Feijoo J, Sampaolesi JR. A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma. Clin Ophthalmol 2012;6: 441-6.
  7. Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea 2010;29:618-21. https://doi.org/10.1097/ICO.0b013e3181c325b2
  8. Rossi GC, Tinelli C, Pasinetti GM, Milano G, Bianchi PE. Dry eye syndromerelated quality of life in glaucoma patients. Eur J Ophthalmol 2009;19:572-9. https://doi.org/10.1177/112067210901900409
  9. Stewart WC, Stewart JA, Nelson LA. Ocular surface disease in patients with ocular hypertension and glaucoma. Curr Eye Res 2011;36:391-8. https://doi.org/10.3109/02713683.2011.562340
  10. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 2008;17:350-5. https://doi.org/10.1097/IJG.0b013e31815c5f4f
  11. Narayanan S, Miller WL, McDermott AM. Conjunctival cytokine expression in symptomatic moderate dry eye subjects. Invest Ophthalmol Vis Sci 2006;47: 2445-50. https://doi.org/10.1167/iovs.05-1364
  12. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr Eye Res 1999;19:201-11. https://doi.org/10.1076/ceyr.19.3.201.5309
  13. Massingale ML, Li X, Vallabhajosyula M, Chen D, Wei Y, Asbell PA. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea 2009;28: 1023-7. https://doi.org/10.1097/ICO.0b013e3181a16578
  14. Yoon KC, Jeong IY, Park YG, Yang SY. Interleukin-6 and tumor necrosis factoralpha levels in tears of patients with dry eye syndrome. Cornea 2007;26:431-7. https://doi.org/10.1097/ICO.0b013e31803dcda2
  15. Lam H, Bleiden L, de Paiva CS, Farley W, Stern ME, Pflugfelder SC. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol 2009;147: 198-205. https://doi.org/10.1016/j.ajo.2008.08.032
  16. Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol 2004;137:337-42. https://doi.org/10.1016/j.ajo.2003.10.036
  17. Jeon BH, Kim CS, Kim HS, Park JB, Nam KY, Chang SJ. Effect of Korean red ginseng on blood pressure and nitric oxide production. Acta Pharmacol Sin 2000;21:1095-100.
  18. Jin YR, Yu JY, Lee JJ, You SH, Chung JH, Noh JY, Im JH, Han XH, Kim TJ, Shin KS, et al. Antithrombotic and antiplatelet activities of Korean red ginseng extract. Basic Clin Pharmacol Toxicol 2007;100:170-5. https://doi.org/10.1111/j.1742-7843.2006.00033.x
  19. Sung J, Han KH, Zo JH, Park HJ, Kim CH, Oh BH. Effects of red ginseng upon vascular endothelial function in patients with essential hypertension. Am J Chin Med 2000;28:205-16. https://doi.org/10.1142/S0192415X00000258
  20. Bae EA, Hyun YJ, Choo MK, Oh JK, Ryu JH, Kim DH. Protective effect of fermented red ginseng on a transient focal ischemic rats. Arch Pharm Res 2004;27:1136-40. https://doi.org/10.1007/BF02975119
  21. Kwak YS, Kyung JS, Kim JS, Cho JY, Rhee MH. Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng. Biol Pharm Bull 2010;33:468-72. https://doi.org/10.1248/bpb.33.468
  22. Hwang SY, Son DJ, Kim IW, Kim DM, Sohn SH, Lee JJ, Kim SK. Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits. Phytother Res 2008;22:778-83. https://doi.org/10.1002/ptr.2363
  23. Oh KJ, Chae MJ, Lee HS, Hong HD, Park K. Effects of Korean red ginseng on sexual arousal in menopausal women: placebo-controlled, double-blind crossover clinical study. J Sex Med 2010;7:1469-77. https://doi.org/10.1111/j.1743-6109.2009.01700.x
  24. Heo JH, Lee ST, Chu K, Oh MJ, Park HJ, Shim JY, Kim M. An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease. Eur J Neurol 2008;15:865-8. https://doi.org/10.1111/j.1468-1331.2008.02157.x
  25. Babayigit A, Olmez D, Karaman O, Bagriyanik HA, Yilmaz O, Kivcak B, Erbil G, Uzuner N. Ginseng ameliorates chronic histopathologic changes in a murine model of asthma. Allergy Asthma Proc 2008;29:493-8. https://doi.org/10.2500/aap.2008.29.3137
  26. Baek NI, Kim DS, Lee YH, Park JD, Lee CB, Kim SI. Ginsenoside Rh4, a genuine dammarane glycoside from Korean red ginseng. Planta Med 1996;62:86-7. https://doi.org/10.1055/s-2006-957816
  27. Kunert KS, Tisdale AS, Stern ME, Smith JA, Gipson IK. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthal 2000;118:1489-96. https://doi.org/10.1001/archopht.118.11.1489
  28. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000;107:631-9. https://doi.org/10.1016/S0161-6420(99)00176-1
  29. Kim NR, Kim JH, Kim CY. Effect of Korean red ginseng supplementation on ocular blood flow in patients with glaucoma. J Ginseng Res 2010;34:237-45. https://doi.org/10.5142/jgr.2010.34.3.237
  30. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995;21:221-32.
  31. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthal 2000;118:615-21. https://doi.org/10.1001/archopht.118.5.615
  32. Jaenen N, Baudouin C, Pouliquen P, Manni G, Fiqueiredo A, Zeyen T. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Opthalmol 2007;17:341-9. https://doi.org/10.1177/112067210701700311
  33. Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 2010;29: 312-34. https://doi.org/10.1016/j.preteyeres.2010.03.001
  34. Noecker RJ, Herrygers LA, Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea 2004;23:490-6. https://doi.org/10.1097/01.ico.0000116526.57227.82
  35. Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci 2005;46:2444-50. https://doi.org/10.1167/iovs.04-1331
  36. Debbasch C, Brignole F, Pisella PJ, Warnet JM, Rat P, Baudouin C. Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci 2001;42: 642-52.
  37. Okada Y. Effects of topical antiglaucoma medications on corneal epithelium as evaluated by gene expression patterns. Cornea 2007;26:S46-54. https://doi.org/10.1097/ICO.0b013e31812f6a71
  38. Baudouin C, Pisella PJ, Fillacier K, Goldschild M, Becquet F, De Saint Jean M, Bechetoille A. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 1999;106: 556-63. https://doi.org/10.1016/S0161-6420(99)90116-1
  39. Pisella PJ, Debbasch C, Hamard P, Creuzot-Garcher C, Rat P, Brignole F, Baudouin C. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci 2004;45:1360-8. https://doi.org/10.1167/iovs.03-1067
  40. Xiong C, Chen D, Liu J, Liu B, Li N, Zhou Y, Liang X, Ma P, Ye C, Ge J, et al. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride. Invest Ophthalmol Vis Sci 2008;49:1850-6. https://doi.org/10.1167/iovs.07-0720
  41. Rivas L, Oroza MA, Perez-Esteban A, Murube-del-Castillo J. Morphological changes in ocular surface in dry eyes and other disorders by impression cytology. Graefes Arch Clin Exp Ophthalmol 1992;230:329-34. https://doi.org/10.1007/BF00165940
  42. Hikichi T, Yoshida A, Tsubota K. Lymphocytic infiltration of the conjunctiva and the salivary gland in Sjogren's syndrome. Arch Ophthal 1993;111:21-2.
  43. Stern ME, Gao J, Schwalb TA, Ngo M, Tieu DD, Chan CC, Reis BL, Whitcup SM, Thompson D, Smith JA. Conjunctival T-cell subpopulations in Sjogren's and non-Sjogren's patients with dry eye. Invest Ophthalmol Vis Sci 2002;43: 2609-14.
  44. Tsubota K, Fujihara T, Saito K, Takeuchi T. Conjunctival epithelium expression of HLA-DR in dry eye patients. Ophthalmologica 1999;213:16-9. https://doi.org/10.1159/000027387
  45. Grus FH, Dick B, Augustin AJ, Pfeiffer N. Analysis of the antibody repertoire in tears of dry-eye patients. Ophthalmologica 2001;215:430-4. https://doi.org/10.1159/000050903
  46. Rand AL, Asbell PA. Nutritional supplements for dry eye syndrome. Curr Opin Ophthalmol 2011;22:279-82. https://doi.org/10.1097/ICU.0b013e3283477d23
  47. Barabino S, Rolando M, Camicione P, Ravera G, Zanardi S, Giuffrida S, Calabria G. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea 2003;22:97-101. https://doi.org/10.1097/00003226-200303000-00002
  48. Aragona P, Bucolo C, Spinella R, Giuffrida S, Ferreri G. Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjogren's syndrome patients. Invest Ophthalmol Vis Sci 2005;46:4474-9. https://doi.org/10.1167/iovs.04-1394
  49. Macri A, Giuffrida S, Amico V, Iester M, Traverso CE. Effect of linoleic acid and gamma-linolenic acid on tear production, tear clearance and on the ocular surface after photorefractive keratectomy. Graefes Arch Clin Exp Ophthalmol 2003;241:561-6. https://doi.org/10.1007/s00417-003-0685-x
  50. Park BG, Jung HJ, Cho YW, Lim HW, Lim CJ. Potentiation of antioxidative and anti-inflammatory properties of cultured wild ginseng root extract through probiotic fermentation. J Pharm Pharmacol 2013;65:457-64. https://doi.org/10.1111/jphp.12004
  51. Abdel-Wahhab MA, Ahmed HH. Protective effects of Korean Panax ginseng against chromium VI toxicity and free radical generation in rat. J Ginseng Res 2004;28:11-7. https://doi.org/10.5142/JGR.2004.28.1.011
  52. Lee SH, Jung BH, Kim SY, Lee EH, Chung BC. The antistress effect of ginseng total saponin and ginsenoside Rg3 and Rb1 evaluated by brain polyamine level under immobilization stress. Pharmacol Res 2006;54:46-9. https://doi.org/10.1016/j.phrs.2006.02.001
  53. Cho WC, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol 2006;550: 173-9. https://doi.org/10.1016/j.ejphar.2006.08.056
  54. Song SB, Tung NH, Quang TH, Nqan NT, Kim KE, Kim YH. Inhibition of TNFalpha- mediated NF-kappaB Transcriptional Activity in HepG2 Cells by Dammarane- type Saponins from Panax ginseng Leaves. J Ginseng Res 2012;36: 146-52. https://doi.org/10.5142/jgr.2012.36.2.146
  55. Ly S, Yi PF, Shen HQ, Zhang LY, Dong HB, Wu SC, Xia F, Guo X, Wei XB, Fu BD. Ginsenoside Rh2-B1 stimulates cell proliferation and IFN-gamma production by activating the p38 MAPK and ERK-dependent signaling pathways in CTLL-2 cells. Immunopharmacol Immunotoxicol 2014;36:43-51. https://doi.org/10.3109/08923973.2013.864669
  56. Lee IA, Hyam SR, Jang SE, Han MJ, Kim DH. Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages. J Agric Food Chem 2012;60:9595-602. https://doi.org/10.1021/jf301372g
  57. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-93. https://doi.org/10.1016/S0006-2952(99)00212-9
  58. Kim WK, Song SY, Oh WK, Kaewsuwan S, Tran TL, Kim WS, Sung JH. Woundhealing effect of ginsenoside Rd from leaves of Panax ginseng via cyclic AMPdependent protein kinase pathway. Eur J Pharmacol 2013;702:285-93. https://doi.org/10.1016/j.ejphar.2013.01.048
  59. Zang YX, Wang L, Xiao EL, Li SJ, Chen JJ, Gao B, Min GN, Wang ZP, Wu YJ. Ginsenoside-Rd exhibits anti-inflammatory activities through elevation of antioxidant enzyme activities and inhibition of JNK and ERK activation in vivo. Int Immunopharmacol 2013;17:1094-100. https://doi.org/10.1016/j.intimp.2013.10.013
  60. Her Y, Lim JW, Han SH. Dry eye and tear film functions in patients with psoriasis. Jpn J Ophthalmol 2013;57:341-6. https://doi.org/10.1007/s10384-012-0226-4
  61. Shimazaki-Den S, Dogru M, Higa K, Shimazaki J. Symptoms, visual function, and mucin expression of eyes with tear film instability. Cornea 2013;32: 1211-8. https://doi.org/10.1097/ICO.0b013e318295a2a5

Cited by

  1. Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study vol.10, pp.None, 2016, https://doi.org/10.2147/opth.s96433
  2. Evaluation of Ocular Surface Condition in the Tattoo on Eyelid Margin by Noninvasive Keratograph vol.6, pp.1, 2015, https://doi.org/10.12677/hjo.2017.61002
  3. 안구건조증에 대한 Rg3진센약침의 임상적 효과 6례 보고 vol.39, pp.5, 2015, https://doi.org/10.22246/jikm.2018.39.5.929
  4. Complete Biotransformation of Protopanaxadiol-Type Ginsenosides into 20-O-β-Glucopyranosyl-20(S)-protopanaxadiol by Permeabilized Recombinant Escherichia coli Cells Coexpressing β-Glucosidas vol.67, pp.30, 2015, https://doi.org/10.1021/acs.jafc.9b02592
  5. The Case for a More Holistic Approach to Dry Eye Disease: Is It Time to Move beyond Antibiotics? vol.8, pp.3, 2015, https://doi.org/10.3390/antibiotics8030088